Evidence map›Paper›PMID 32562550›Full record

ArticleEuropean journal of clinical investigation2020

COVID-19: Some clinical questions after the first 4 months.

Matteo Bassetti, Filippo Ansaldi, Giancarlo Icardi, Paolo Pelosi, Chiara Robba, Lucia Taramasso, Cecilia Trucchi, Antonio Vena, Daniele Roberto Giacobbe

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of clinical investigation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Matteo BassettiClinica Malattie Infettive, Ospedale Policlinico San Martino - IRCCS, Genoa, Italy.ORCID https://orcid.org/0000-0002-0145-9740
Filippo AnsaldiDepartment of Health Sciences, University of Genoa, Genoa, Italy.
Giancarlo IcardiDepartment of Health Sciences, University of Genoa, Genoa, Italy.
Paolo PelosiAnaesthesia and Intensive Care, Ospedale Policlinico San Martino - IRCCS for Oncology and Neuroscience, Genoa, Italy.
Chiara RobbaAnaesthesia and Intensive Care, Ospedale Policlinico San Martino - IRCCS for Oncology and Neuroscience, Genoa, Italy.
Lucia TaramassoClinica Malattie Infettive, Ospedale Policlinico San Martino - IRCCS, Genoa, Italy.
Cecilia TrucchiHealth Planning Unit, Azienda Ligure Sanitaria della Regione Liguria (A.Li.Sa.), Genoa, Italy.
Antonio VenaClinica Malattie Infettive, Ospedale Policlinico San Martino - IRCCS, Genoa, Italy.
Daniele Roberto GiacobbeClinica Malattie Infettive, Ospedale Policlinico San Martino - IRCCS, Genoa, Italy.ORCID https://orcid.org/0000-0003-2385-1759

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Age FactorsAntibodies, Monoclonal, HumanizedAnti-Inflammatory AgentsAntiviral AgentsBetacoronavirusComorbidityCoronavirus InfectionsCOVID-19COVID-19 Drug TreatmentCOVID-19 VaccinesCytokine Release SyndromeGenetic Predisposition to DiseaseHumansLymphohistiocytosis, HemophagocyticPandemicsPneumonia, ViralAntibodies, Monoclonal, HumanizedAnti-Inflammatory AgentsAntiviral AgentsCOVID-19 VaccinestocilizumabViral Vaccines

Identifiers

PMID32562550
PMCPMC7323159

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.